BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26516160)

  • 1. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
    Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
    Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer.
    Tian J; Doi H; Saar M; Santos J; Li X; Peehl DM; Knox SJ
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1179-85. PubMed ID: 24210080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin Radiosensitizes EGF Receptor-knockdown Prostate Cancer Cells by Attenuating DNA Repair Pathways.
    Rajput M; Mishra D; Kumar K; Singh RP
    J Cancer Prev; 2022 Sep; 27(3):170-181. PubMed ID: 36258717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.
    Konsoula Z; Cao H; Velena A; Jung M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerumbone Regulates DNA Repair Responding to Ionizing Radiation and Enhances Radiosensitivity of Human Prostatic Cancer Cells.
    Chiang PK; Tsai WK; Chen M; Lin WR; Chow YC; Lee CC; Hsu JM; Chen YJ
    Integr Cancer Ther; 2018 Jun; 17(2):292-298. PubMed ID: 28602099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.
    Gandhi N; Wild AT; Chettiar ST; Aziz K; Kato Y; Gajula RP; Williams RD; Cades JA; Annadanam A; Song D; Zhang Y; Hales RK; Herman JM; Armour E; DeWeese TL; Schaeffer EM; Tran PT
    Cancer Biol Ther; 2013 Apr; 14(4):347-56. PubMed ID: 23358469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
    Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M
    Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
    Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
    Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
    Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
    Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
    Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo.
    Kwon SJ; Lee SK; Na J; Lee SA; Lee HS; Park JH; Chung JK; Youn H; Kwon J
    Mol Cancer Ther; 2015 Feb; 14(2):597-607. PubMed ID: 25504753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
    Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins.
    Jeong YK; Kim MS; Lee JY; Kim EH; Ha H
    PLoS One; 2015; 10(11):e0143596. PubMed ID: 26599019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
    Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
    Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.